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Zn and DHA have putative neuroprotective effects and these two essential nutrients are known to interact biochemically. We aimed to identify
novel protein candidates that are differentially expressed in human neuronal cell line M17 in response to Zn and DHA that would explain the
molecular basis of this interaction. Two-dimensional gel electrophoresis and MS were applied to identify major protein expression changes in
the protein lysates of human Ml7 neuronal cells that had been grown in the presence and absence of Zn and DHA. Proteomic findings were further
investigated using Western immunoblot and real-time PCR analyses. Four protein spots, which had significant differential expression, were
identified and selected for in-gel trypsin digestion followed by matrix-assisted laser desorption ionisation MS analysis. The resultant peptide
mass fingerprint for each spot allowed their respective identities to be deduced. Two human histone variants H3 and H4 were identified. Both
H3 and H4 were downregulated by Zn in the absence of DHA (Zn effect) and upregulated by DHA (DHA effect) in the presence of Zn
(physiological condition). These proteomic findings were further supported by Western immunoblot and real-time PCR analyses using H3- and
H4-specific monoclonal antibodies and oligonucleotide primers, respectively. We propose that dietary Zn and DHA cause a global effect on
gene expression, which is mediated by histones. Such novel information provides possible clues to the molecular basis of neuroprotection by
Zn and DHA that may contribute to the future treatment, prevention and management of neurodegenerative diseases such as Alzheimer’s disease.
Zinc: n-3 Fatty acids: DHA: M17 human neuronal cells: Histone H3: Histone H4
Neuronal cell damage or death (apoptosis) is a key feature in
the pathology of neurodegenerative disorders, such as ischae-
mic stroke, Alzheimer’s disease (AD) and Parkinson’s
disease(1). Therefore, neuronal cell survival is pivotal in
preventing such neurodegenerative disorders. Importantly,
identification and characterisation of the critical modulators
of neuronal cell survival are of paramount significance to
elucidate the mechanisms underlying neurological diseases
and thus facilitate the development of novel treatment strat-
egies. Another common feature seen in AD brains is lesions
of extracellular amyloid plaques, which consist of protein
aggregates of b-amyloid(2,3). Significantly, free neuronal Zn
has been shown to promote aggregation of the b-amyloid(4),
and increased levels of Zn are reportedly colocalised in the
brain of AD patients(5).
Epidemiological studies have shown that people who ingest
higher levels of n-3 fatty acids, such as DHA, are less likely to
develop neurodegenerative diseases like AD(6). Similarly, low
blood levels of n-3 fatty acids have been linked to neuropsy-
chiatric conditions such as depression(7) and AD(8). Fish are an
excellent source of dietary DHA, yet regular consumption of
fish is often uncommon in the typical Western diet (Australian
Fisheries Management Authority). Improved mental develop-
ment has been observed in human subjects with adequate
dietary supply of DHA during infancy(9). Another link between
DHA and AD is revealed by the finding that AD patients have a
reduced amount of DHA in phospholipids in the hippocampal
area(10). Additionally, provision of DHA has been linked to
lower amyloid plaque production in AD brains. In one such
example, amyloid precursor protein transgenic mice on DHA-
supplemented diets displayed a decreased amount of b-amyloid
production compared with mice on control diets(11), suggesting
a role of DHA in inhibiting plaque formation. This theory is
supported by an assay performed on cortical extracts of mice
placed on low and high DHA-containing diets, revealing a
significant reduction of b-amyloid levels in the brains of
mice fed on the DHA-enriched diets compared with brains
of mice fed on the DHA-deficient diet(12).
An association between DHA levels in the brain and Zn
homeostasis has been found, which is particularly interesting
due to the neuroprotective roles of Zn and n-3 fatty acids.
Studies on Zn-deficient pregnant rats have showed a decrease
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in PUFA synthesis and impaired transport of PUFA to
foetuses(13), leading to whole-body depletion of maternal
stores of n-6 and n-3 PUFA(14).
We have previously demonstrated that a dietary-induced
reduction of brain DHA in rats can cause overexpression of
ZnT3, a transmembrane protein involved in transport of Zn
into synaptic vesicles(15). Although Zn is an important nutrient
as an essential catalytic and/or structural cofactor in many Zn-
dependent enzymes, in high concentrations, Zn is toxic and
causes neuronal cell damage, which is seen in brain ischaemia,
trauma and epilepsy(4). Moreover, Zn induces formation of
amyloid plaques and brain cell death, which are significant
features of aging-related neurodegenerative processes like
AD(16). Since high levels of synaptic Zn are commonly seen
in AD brains, these results suggest a likely synergy between
Zn and DHA in AD pathophysiology. Using proteomic anal-
ysis, we aimed to identify novel human neuronal proteins
that are affected by both Zn and DHA. Here, we report for
the first time that Zn and DHA affect the expression levels
of histones H3 and H4 in the human neuronal cell line M17.
This novel discovery that changes in Zn and DHA have a
major effect on histone gene expression levels will contribute
to understanding the molecular biology of AD and the devel-
opment of intervention strategies.
Methods
Cell culture
The human neuroblastoma cell line M17 was grown at 378C in
a humidified atmosphere in the presence of 5·0 % CO2, as
monolayer cultures in 75 cm2 disposable plastic flasks
(Nunce, Roskilde, Denmark), maintained in 10 ml Opti-
MEM media (a modified minimum essential medium
(Eagle’s) media) with heat inactivated 2·5 % foetal bovine
serum supplementation. At approximately 90 % confluence,
M17 cells were harvested or passaged using 0·025 % trypsin/
EDTA or 0·05 % trypsin/EDTA, respectively.
M17 cells were seeded at a density of 1 £ 106 cells/75 cm2
flask and grown in media supplemented with DHA (DHA,
Sigma Aldrich, St Louis, MO, USA; 10mg/ml final concen-
tration; pre-incubated overnight at 378C to allow the DHA
to conjugate with media proteins to allow delivery into
cells) or without DHA and with (5mM final concentration)
or without ZnCl2. After 2 d of incubation, the cells were har-
vested, centrifuged at 1000 g for 5 min and pellet resuspended
in PBS. Each sample was then divided into aliquots, centri-
fuged at 14 000 g for 5 min and cell pellets stored at 2808C
until needed for analysis.
Two-dimensional PAGE
Cell pellets were resuspended in ZOOM protein solubilizer
1 lysis buffer (Invitrogen, Carlsbad, CA, USA), disrupted by
passing through a twenty-one-gauge needle and sonicated by
using a Microson Ultrasonic cell disrupter (Misonix Incorpor-
ated, Farmingdale, NY, USA), following the manufacturer’s
instructions. Samples were then centrifuged at 14 000 g for
20 min at 48C and stored in small aliquots at 2808C until
needed for analysis.
Quantification of the protein concentration in cell lysates
was performed using Quant-ITe Protein Assay Kit (Invitrogen)
and Qubite Fluorometer, following the manufacturer’s
instructions.
First (isoelectric focusing) dimension of reduced and alkyl-
ated cell lysates was resolved on pH 3–12 ZOOM IPG strips
(Invitrogen) followed by the second dimension on precast
4–20 % Tris–glycine ZOOM gels (Invitrogen) following the
manufacturer’s instructions.
Gels were stained with SYPRO Ruby protein gel stain
(Invitrogen) according to the manufacturer’s instructions and
detected using Fujifilm LAS-300 UV transilluminator (Fuji-
film, Melbourne, Vic, Australia) to visualise protein spots.
MS analysis
Individual gel plugs containing the protein samples of interest
were excised from each gel by automated robotic cutter and
placed into sequential wells in a ninety-six-well format plate
and subjected to two rounds of destaining with 25 mM-
ammonium bicarbonate and dehydration with 50 % aceto-
nitrile. The gel plugs were then fully dehydrated at 378C
before digestion with porcine trypsin for l6 h at 378C. Diges-
tion products were released from the gel plugs by sonication
and acidified using 1 % trifluoroacetic acid. The peptides
were then purified using a C18 zip tip according to the man-
ufacturer’s instructions (Varian, Palo Alto, CA, USA) and
eluted on to the Applied Biosystems, Inc. (ABI) MS target
in a-cyano-4-hydroxycinnamic acid matrix. The target was
then analysed immediately by matrix-assisted laser desorption
ionisation-time of flight/time of flight MS using the ABI 4700
Proteomics Analyser (ABI, CA, USA) immediately. Samples
were initially analysed in single MS mode to determine the
peptide mass fingerprint of the sample. The ten most intense
peptide peaks were then isolated, fragmented and analysed
in tandem MS/MS mode to determine de novo amino acid
sequence of the peptides selected. A combined protein score
for the peptide mass fingerprint and ten most intense peptides
were obtained using the Mascot bioinformatic search engine
(Department of Primary Industries, Melbourne, Vic, Australia)
to search the non-redundant National Center for Biotechnol-
ogy Information, Homo sapiens database, mass tolerance
100 ppm and oxidation as a variable modification. Proteins
were identified via their peptide mass fingerprint and deduced
amino acid sequence determined by single MS and tandem
MS/MS, respectively. Protein identity was only reported for
samples that gave a significant (P,0·05) molecular weight
search score.
One-dimensional electrophoresis and Western immunoblot
analysis
Cell lysates (described above) were resolved on 15 % SDS-
PAGE gels following our established techniques(17).
For Western analysis, the SDS-PAGE gels were transferred
onto a nitrocellulose membrane (Pall Life Science, Pensacola,
FL, USA) and blocked with 1 % (w/v) non-fat skim milk
in TBS, following our standard methods(17). Membranes
were incubated with 1/1000 dilution of monoclonal mouse
anti-human H3 and H4 (Abchem, Sydney, NSW, Australia)
antibodies and antibody binding detected with anti-mouse
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(Chemicon International, Temecula, CA, USA) horseradish
peroxidase secondary antibody (diluted 1/4000) following
our standard techniques(17). Antibody binding proteins were
visualised using Immobilan Western chemiluminescent horse-
radish peroxidase substrate (Millipore Corporation, Temecula,
CA, USA) according to the manufacturer’s instructions.
Developed membranes were stripped for 15 min at room
temperature using 1 ml Re-blot Plus-strong (Chemicon Inter-
national) diluted in 1:10 in Milli-Q water. In order to ensure
equal protein loading, the membranes were reprobed for
b-actin using mouse anti-b-actin (Sigma Aldrich) primary
antibody (1/5000 dilution) followed by anti-mouse horseradish
peroxidase antibody (Chemicon International) and developed
as described above.
Real-time PCR analysis
Total RNA was isolated from cell pellets using RNeasy Mini-
kit (Qiagen, Doncaster, Vic, Australia) according to the man-
ufacturer’s instructions, along with DNA-free treatment
(Ambion, Austin, TX, USA) to remove genomic DNA. The
RNA concentration and purity were spectrophotometrically
measured on Nanodrop ND-1000 (NanoDrop Technologies,
Wilmington, DE, USA). First strand of cDNA was synthesised
from 1mg total RNA template by using High-Capacity cDNA
Reverse-Transcription kit (ABI), and quantitative real-time
PCR was performed, in triplicate, on 7500 Real-Time PCR
System (ABI), using 1 £ SYBR Green PCR Master Mix
(ABI) and specific primers to human histone H3 (forward:
50-AATCGACCGGTGGTAAAGCA-30; reverse: 50-TTGCG-
AGCGGCTTTTGTA-30) and H4 (forward: 50-TTATGAGGA-
AACTCGCGGAGTG-30; reverse: 50-TGGCTGTGACTGTC-
TTGCGTT-30), following the manufacturer’s instructions.
Glyceraldehyde-3-phosphate dehydrogenase was used as the
endogenous control. Expression levels for each sample were
calculated using D cross-over threshold (Ct) method where
the data were normalised by determining the difference in
Ct values between H3 or H4 genes and glyceraldehyde-3-
phosphate dehydrogenase. The fold change was calculated as
22DDCt, where the DDCt is the difference between the treated
DCt and control DCt. Significance (P,0·05) was tested by the
Student’s t-test.
Results
Proteomic analysis of human neuronal cells with and without
zinc and DHA
In the present study, we cultured human neuronal M17 cells in
the presence and absence of Zn and DHA to identify novel
proteins that are either up- or downregulated in response to
Zn and DHA.
Fig. 1. Effect of zinc on protein expression in M17 human neuronal cells.
Proteome expression of M17 cells grown in the absence of DHA and without
zinc (a) or with zinc (final concentration of 5mM) (b). Five microlitres of
molecular mass markers (Mr) were run concurrently and gels stained with
SYPRO Ruby staining. Protein spots of significant difference (ˆ ) were
subjected to MS analysis (S1, S2).
Fig. 2. Effect of DHA on protein expression in M17 human neuronal cells.
Proteome expression of M17 cells grown in the presence of zinc (final
concentration of 5mM) and no DHA (a) or with 10mg/ml DHA (b). Five
microlitres of molecular mass markers (Mr) were run concurrently and gels
stained with SYPRO Ruby staining. Protein spots of significant difference
(ˆ ) were subjected to MS analysis (S3, S4).
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We subjected total protein lysates of M17 cells to two-
dimensional (2D) gel electrophoresis and stained with
SYPRO Ruby fluorescent stain to visualise differentially
expressed protein spots. We first looked at the effect of Zn
on M17 proteins in absence of DHA (Fig. 1). Many protein
spots were significantly increased following treatment of the
M17 cells with 5mM Zn (Fig. 1(b)). We observed there
were two basic spots at about 11 and 15 kDa, which showed
a significant reduction in protein amounts (S1 and S2 in
Fig. 1(a)) and these were chosen for MS analysis.
The effect of DHA on M17 cells in the presence of Zn was
also investigated by 2D analysis (Fig. 2). We observed a sig-
nificant reduction in the number and level of protein spots
with 10mg/ml DHA treatment; however, the protein levels
of two spots were significantly increased with the DHA
treatment (S3 and S4 in Fig. 2(b)). These two spots occupied
similar isoelectric point and molecular mass as those seen in
Zn-deficient cells (S1 and S2 in Fig. 1(a)). These spots were
therefore selected for MS analysis.
When we compared additional treatments of
‘ 2 Zn þ DHA’ with ‘ þ Zn 2 DHA’ and 2Zn þ DHA
with ‘ þ Zn þ DHA’, no significant difference on H3 and
H4 levels was observed (data not shown). As Zn and DHA
have opposing effects on H3 and H4 levels, treatments of
2Zn þ DHA and þZn 2 DHA may cancel each other out
and therefore show no significant difference. Moreover, com-
paring 2Zn þ DHA with þZn þ DHA did not show signifi-
cant difference also, suggesting that Zn does not affect
upregulation caused by DHA.
The protein spots S1–S4 (Figs. 1 and 2, respectively) were
precisely excised by an automated robotic cutter, in-gel
digested by trypsin and the peptide fingerprints subjected to
MS analysis. Upon Homo sapiens National Center for Bio-
technology Information database searches, the identities of
Table 1. MS protein identity summary table*
Two-dimensional protein spot Protein name Species Accession no. Protein Mr Protein pI Protein score (%)
S1 H3 histone, family 3A Homo sapiens gij51859376 15 346·5 11·14 100
S2 HIST2H4 protein Homo sapiens gij124504316 11 370·4 11·36 100
S3 H3 histone, family 3A Homo sapiens gij51859376 15 346·5 11·14 100
S4 HIST2H4 protein Homo sapiens gij124504316 11 370·4 11·36 100
pI, Isoelectric point; Mr, molecular mass.
* Protein spots S1–S4 were excised from each gel by automated robotic cutter and subjected to trypsin digest followed by MS analysis and submission of peptide fingerprints
to Homo sapiens National Center for Biotechnology Information database searches. Proteins were identified via their peptide mass fingerprint and deduced amino acid
sequence determined by single MS and tandem MS/MS, respectively. Protein identity was only reported for samples that gave a significant (P,0·05) molecular weight
search score.
Fig. 3. Western blot analysis of H3 (a) and b-actin (b) expression in M17 cells grown in media supplemented with (þ ) or without (2 ) zinc (final concentration of
5mM) and with (þ) or without (2 ) 10mg/ml DHA. (c) Densitometric analysis in arbitrary units (AU) are shown as means with their standard errors (n 3), *P,0·05.
Molecular mass protein markers (Mr) are indicated on the left of each gel.
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the spots were revealed with a score of 100 % match (Table 1).
Both S1 and S3 spots were identified as human histone H3
(isoelectric point 11·1, 15·3 kDa), while spots S2 and S4
were identified as human histone H4 (isoelectric point 11·4,
11·4 kDa) matching perfectly with the isoelectric point and
molecular mass observed in the 2D gels (Figs. 1 and 2,
Table 1).
To validate our proteomic findings, we investigated human
histone H3 and H4 proteins and mRNA levels using Western
and real-time PCR analyses, respectively.
Western blot analysis of human histones H3 and H4
Using monoclonal antibodies specific to human histone H3
and H4, we subjected the same M17 total protein cell lysates
as used in 2D analysis to Western blot analysis. In the absence
of DHA, both histones H3 and H4 were downregulated
upon Zn treatment (Zn effect; Figs. 3(a) and 4(a), correlating
with the 2D results (Fig. 1). In the presence of Zn and
DHA (DHA effect), both histones H3 and H4 were upregu-
lated (Figs. 3(a) and 4(b)), again correlating with the 2D
results (Fig. 2). To ensure that the observed changes in protein
levels were not attributed to unequal protein loading of the
wells of the gels, we probed the same blots with b-actin
housekeeping protein, and this showed that there were equal
protein-banding intensities (Figs. 3(b) and 4(b)). Furthermore,
densitometric analysis of the protein bands in relation to
b-actin indicated significant difference in expression levels
(Figs. 3(c) and 4(c)).
Real-time PCR analysis of human histones H3 and H4
In order to investigate whether changes in protein levels of
histones H3 and H4 correlated with mRNA levels in M17
cells treated with and without Zn and DHA, we performed
real-time PCR analysis. In the absence of DHA, both his-
tones H3 and H4 showed significant downregulation of
mRNA levels in response to Zn treatment (21·8- and
21·5-fold difference between treatment and control, respect-
ively; Fig. 5). In the presence of Zn, both histones H3 and
H4 demonstrated significant upregulation of mRNA levels in
response to DHA (0·8- and 1·2-fold difference between
treatment and control, respectively; Fig. 5). Taken together,
the changes observed in mRNA levels of histones H3
and H4, with Zn and with and without DHA (Fig. 5), cor-
related well with the changes observed in protein levels
(Figs. 1–4).
Sequence analysis
Having demonstrated the effects of Zn and DHA on H3 and
H4 proteins and mRNA levels in M17 human neuronal
cells, we next analysed the sequences of these histones to
reveal molecular details that would help us to understand
the connection between the histones H3/H4, Zn and DHA.
Comparison of nucleic and amino acid sequences between
human H3 and H4 shows minimal sequence identities. H3
and H4 have only 44·8 % nucleic acid identity and only
20·6 % amino acid identity (Table 2). It is interesting to note
that there is 100 % amino acid identity between human and
Fig. 4. Western blot analysis of H4 (a) and b-actin (b) expression in M17 cells grown in media supplemented with (þ ) or without (2 ) zinc (final concentration of
5mM) and with (þ) or without (2) 10mg/ml DHA. (c) Densitometric analysis in arbitrary units (AU) are shown as means with their standard errors (n 3), *P,0·05.
Molecular mass protein markers (Mr) are indicated on the left of each gel.
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mouse H3 and H4, such that similar effects of Zn and DHA on
histones could be predicted in the mouse.
Since Zn had an effect on the expression levels of histones
H3 and H4, we searched 4000 bp upstream from the start
codon of these histones for transcription-binding motifs.
Indeed, we identified metal responsive elements (MRE) in
both H3 and H4 (Table 3). Both histones H3 and H4 are
present on two different chromosome clusters (e. g. clusters
1 and 2). For histone H3, one MRE is present in cluster 1
(located 2610 bp upstream from the start codon), while two
MRE are present in cluster 2 (located 743 and 919 bp
upstream from the start codon; Table 3). For histone H4,
two MRE are present in cluster 1 (located 1405 and 1995 bp
upstream from the start codon), while no MRE was detected
in cluster 2 (Table 3).
Discussion
Neurodegenerative disease, aims and findings
Neurodegeneration imparts huge personal and financial costs
upon sufferers, their family/carer(s) and society as a whole.
These costs are predicted to rise over time in the absence of
effective treatments. Given what is known in regards to the
protective effect of DHA(18 – 20), and the deleterious effects
of its deficiency on neuronal health(4,14,21), basic questions
remain about the underlying mechanisms. In addition,
although an essential nutrient and a high concentration of
free cellular Zn induce the formation of amyloid plaques
and brain cell death; these are significant features of aging-
related neurodegenerative processes such as AD. Key to
addressing this is to identify novel proteins regulated by Zn
and DHA. The present study was conducted to answer these
questions, and is based on the well-established data that
both Zn and DHA play an important role in neuroprotection,
perhaps even synergistically, by modulating gene and protein
expression, and critically, the activity of survival signalling
pathways. The discovery that histones, particularly H3 and
H4, are consistently differentially expressed as a result of
Zn and DHA supplementation provides evidence to support
this hypothesis.
In the present study reported here, both H3 and H4 were
significantly downregulated by Zn in the absence of DHA
(Zn effect). On the other hand, both H3 and H4 were
significantly upregulated in M17 human neuronal cells
following DHA treatment in the presence of physiological
Zn levels (DHA effect). This is the first report showing
that Zn and DHA regulate the expression levels of histones
H3 and H4 in the M17 human neuronal cell line.
Histones
Histones are basic nuclear proteins that are responsible for the
nucleosome structure of the chromosomal fibre in eukaryotes.
They play an important role in nucleosome formation and
hence gene expression. The four core histones (H2A, H2B,
H3 and H4) function as one unit, the nucleosome, with Hl
at the periphery. Three strong interactions result in the for-
mation of two dimers (H2A with H2B and H2B with H4)
and one tetramer (H3 with H4). In addition, there are
weaker interactions between H2A and H4, and also between
H2B and H3. There is also an interaction of intermediate
strength between H2A and H3(22). Therefore, it is likely that
H3 and H4, being two of the four histone core subunits, act
as one unit. Our findings that Zn and DHA influenced the
expression of both H3 and H4 proteins in the same direction
(down- or upregulated) are consistent with the known inter-
action of these two histones.
Possible mechanisms on the affect of zinc and DHA on H3 and
H4 expression
We report here that both H3 and H4 possess multiple metal
response elements upstream of their start codons, which
suggests that the transcription of genes is under the control
Fig. 5. Real-time PCR analysis of H3 (a) and H4 (b) expression in M17 cells
treated with zinc-deficient (2 ) and zinc (final concentration of 5mM)-sup-
plemented (þ) media containing no (2 ) or 10mg/ml DHA (þ). Negative
values (less than zero) refer to downregulation/reduction and positive values
(more than zero) refer to upregulation/increase in fold difference of histone
H3 and H4 mRNA between the treatments. Fold difference is the difference
in mRNA levels between – and þ zinc (zinc effect) and – and þ DHA (DHA
effect). Data are shown as means with their standard errors (n 3), *P,0·05,
compared to control (2DHA/2zinc or 2DHA/þzinc).
Table 2. Nucleic (NA) and amino acid (AA) identity and similarity
between human histones H3 and H4*
AA
NA H3 H4
H3 100% 20·6% (34·8%)†
H4 44·8% 100%
*NA and AA sequences were analysed by The European Molecular Biology Open
Software Suite pairwise alignment algorithms on the European Molecular Biology
Laboratory –The European Bioinformatics Institute database (http://www.ebi.ac.
uk/Tools/emboss/align/).
† AA identity (and similarity) between human histones H3 and H4.
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of Zn, possibly through metal-binding transcription factors.
Thus, based on the present findings, we hypothesise that Zn
may inhibit/repress the transcription of histones H3 and H4
in M17 human neuronal cells, resulting in lower histone pro-
tein levels, as observed in the present study. Indeed, there are
emerging studies that show a role for Zn-mediated transcrip-
tional repression, rather than activation, through MRE(23). It
has been reported that inhibition of DNA synthesis terminates
histone protein synthesis indicating that histone synthesis and
DNA synthesis are very tightly linked(24). Although not inves-
tigated here, it is possible that Zn may also affect DNA syn-
thesis and thereby result in the termination of H3 and H4
synthesis in M17 cells. Conversely, we have found that
DHA upregulates expression levels of both H3 and H4 and
abolishes the effect of Zn, suggesting that there is an inter-
action between Zn and DHA in these neuronal cells. The
mechanism for this interaction is not clear; however, the end
result is that Zn and DHA together may increase DNA
synthesis.
The present results are supported by previous studies, which
found that Zn affects histone expression in the mouse
thymus(25). In the present study, the expression of a number
of transcription/translation-related factors, including H3 his-
tone family 3A protein, was influenced by Zn, showing that
dietary Zn can also alter gene expression levels. In a further
study, rats fed a DHA-enriched diet for 2 months displayed
many alterations in gene expression, among which H3 histone,
family 3B was identified(26). Thus, the present results are sup-
ported by other data in the literature suggesting that Zn and
DHA alter histone subunit expression, which in turn may
alter the expression of many other genes. On a different
note, effects of both Zn and DHA on histone expression
may result from effects on the cell cycle. However, in our
M17 human neuronal cell line, cells will be at different
stages of the cell cycle, and cell cycle effects cannot be
ascertained.
Summary, conclusions and future work
In summary, we report for the first time that Zn and DHA alter
expression of histones H3 and H4 in the M17 human neuronal
cell line. We hypothesise that expression of H3 and H4 may
be negatively controlled by Zn via multiple MRE(27). Conver-
sely, DHA may play a role in the upregulation of H3 and H4
in nucleosome formation and gene expression. Under normal
physiological Zn conditions, we propose that DHA facilitates
DNA synthesis resulting in increases in histone protein levels,
as observed in the present study. Thus, we further propose that
DHA may contribute positively to minimising the onset of
neurodegenerative diseases, such as AD, through maintaining
the integrity of neuronal cell DNA synthesis and histone H3
and H4 synthesis. Neurodegenerative diseases may involve
the compromisation of the integrity of neuronal cells through
inhibition of DNA synthesis with consequent termination of
histone synthesis and subsequent apoptosis. The present
research is underway to investigate the direct association of
Zn with H3 and H4 and the effect of DHA on the post-transla-
tional modification of histones. Understanding the molecular
basis of the affect of Zn and DHA in neuroprotection may pro-
vide novel information on the treatment and management of
neurodegenerative diseases.
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